structur
flavaglin
mw
mw
sulfonyl
amidin
mw
shown
figur
sulfonyl
amidin
synthes
accord
describ
procedur
puriti
compound
base
hplc
analys
hypersil
gold
column
mm
thermo
fisher
scientif
waltham
usa
follow
condit
flow
rate
mlmin
buffer
buffer
b
aqueou
trifluoroethano
acid
gradient
buffer
b
min
detect
nm
compound
initi
dissolv
dmso
stock
serial
dilut
dmem
work
solut
final
dmso
concentr
less
vehicledmem
use
control
consist
dmso
dilut
dmem
human
embryon
kidney
cell
line
atcc
cat
cultur
dmem
supplement
fb
unitsml
penicillinstreptomycin
wherea
vero
atcc
cat
cultur
fb
unitsml
penicillinstreptomycin
chikv
use
studi
thai
isol
ecsa
strain
genotyp
ecsa
propag
stock
viru
produc
describ
previous
stock
titer
determin
standard
plaqu
assay
undertaken
essenti
describ
elsewher
immunofluoresc
perform
essenti
describ
previous
incub
cell
pfucel
chikv
hr
presenc
absenc
variou
compound
nm
cell
subsequ
fix
treatment
paraformaldehyd
pb
min
incub
dilut
mous
monoclon
antibodi
santa
cruz
biotechnolog
santa
cruz
ca
usa
dilut
goat
polyclon
antibodi
santa
cruz
biotechnolog
follow
incub
dilut
alexa
fluor
label
donkey
igg
antibodi
invitrogen
thermo
fisher
scientif
waltham
usa
dilut
alexa
fluor
label
donkey
igg
antibodi
invitrogen
thermo
fisher
scientif
cell
visual
olympu
fluoview
confoc
microscop
olympu
tokyo
japan
equip
olympu
fluoview
softwar
v
imag
analysi
calcul
pearson
correl
coeffici
ci
carri
describ
previous
cell
viabil
determin
use
vybrant
mtt
cell
prolifer
assay
kit
invitrogen
thermo
fisher
scientif
accord
manufactur
recommend
percentag
cell
viabil
calcul
averag
eight
sampl
measur
compar
neg
control
vehicledmem
flow
cytometri
determin
cellular
infect
chikv
undertaken
exactli
describ
elsewher
cell
analyz
bd
facalibur
cytomet
becton
dickinson
bd
bioscienc
san
jose
ca
usa
data
analyz
use
cellquesttm
softwar
analysi
induct
apoptosi
respons
chikv
infect
perform
exactli
describ
elsewher
posit
control
cell
treat
dmso
dilut
complet
dmem
hr
experi
undertaken
independ
triplic
cell
seed
six
well
cultur
plate
grown
standard
condit
cell
reach
approxim
confluenc
cell
pre
incub
differ
concentr
sulfonyl
amidin
final
dilut
dmem
time
state
incub
equival
volum
vehicledmem
wash
incub
pfucel
chikv
ecsa
genotyp
absenc
drug
follow
infect
cell
wash
three
time
dmem
complet
medium
contain
compound
equival
vehicledmem
hr
cell
pellet
analyz
flow
cytometri
supernat
standard
plaqu
assay
determin
chikv
titer
experi
compound
ad
design
time
viru
infect
step
experi
undertaken
independ
triplic
duplic
plaqu
assay
cell
seed
six
well
cultur
plate
grown
standard
condit
cell
reach
approxim
confluenc
cell
pre
incub
differ
concentr
sulfonyl
amidin
final
dilut
dmem
incub
equival
volum
vehicledmem
minut
wash
twice
dmem
subsequ
incub
pfucel
chikv
ecsa
genotyp
absenc
drug
follow
infect
cell
wash
three
time
dmem
complet
medium
hr
cell
pellet
analyz
flow
cytometri
supernat
analyz
standard
plaqu
assay
determin
chikv
titer
experi
perform
independ
triplic
duplic
plaqu
assay
stock
chikv
ecsa
genotyp
incub
directli
differ
concentr
sulfonyl
amidin
indic
hr
titer
viru
directli
determin
standard
plaqu
assay
prepar
also
use
infect
cell
cultur
six
well
plate
reach
approxim
confluenc
viral
infect
viral
product
data
analyz
use
graphpad
prism
program
grappad
softwar
statist
analysi
signific
undertaken
pair
sampl
use
spss
spss
chicago
il
usa
p
consid
signific
valu
calcul
use
freewar
softwar
http
previou
studi
identifi
phb
chikv
receptor
protein
major
analysi
undertaken
human
microgli
cell
investig
effect
flavaglin
chikv
entri
studi
decid
use
cell
cell
suitabl
flow
cytometri
analysi
previou
studi
show
cell
express
phb
capabl
bind
chikv
therefor
initi
confirm
chikv
coloc
phb
surfac
cell
previous
shown
cell
shown
figur
found
cell
surfac
express
phb
distinct
coloc
phb
chikv
incub
cell
individu
variou
concentr
compound
investig
hr
assess
cell
viabil
use
mtt
assay
calcul
percentag
cell
viabil
averag
eight
replic
compar
neg
vehicledmem
posit
dmso
control
found
hr
incub
cell
viabil
sulfonyl
amidin
concentr
nm
less
nm
compar
neg
control
howev
saw
signific
cytotox
valu
nm
supplementari
fig
compound
show
approxim
equal
valu
nm
nm
nm
sulfonyl
amidin
calcul
dose
respons
curv
see
supplementari
fig
confirm
result
mtt
assay
cultur
cell
incub
variou
concentr
sulfonyl
amidin
mock
incub
vehicledmem
hr
wash
cell
concentr
drug
hr
employ
incub
close
mimic
infect
protocol
undertaken
later
stage
found
approxim
apoptosi
induct
cell
treat
dmso
posit
control
howev
amount
apoptosi
cell
treat
differ
concentr
nm
compound
investig
compar
neg
control
mock
cell
treat
vehicledmem
supplementari
fig
evalu
potenti
virucid
activ
incub
stock
chikv
directli
compound
separ
differ
concentr
hr
vehicledmem
determin
viru
titer
standard
plaqu
assay
vero
cell
observ
direct
effect
compound
viru
supplementari
fig
repeat
experi
use
viruscompound
mixtur
infect
cell
found
signific
effect
abil
viru
infect
cell
moreov
plaqu
assay
analysi
highest
concentr
treatment
show
signific
effect
viru
product
supplementari
fig
combin
result
show
three
compound
test
possess
virucid
activ
determin
effect
compound
chikv
infect
cultur
cell
without
sulfonyl
amidin
variou
concentr
hr
follow
infect
pfucel
chikv
mock
infect
medium
without
compound
investig
hr
remov
extracellular
viru
wash
three
time
subsequ
incub
cell
complet
medium
standard
condit
presenc
compound
hr
harvest
cell
flow
cytometri
collect
supernat
standard
plaqu
assay
found
reduct
percentag
infect
cell
three
compound
concentr
nm
fig
c
e
wherea
addit
show
signific
reduct
percentag
cell
infect
chikv
nm
fig
similarli
observ
signific
reduct
viral
product
cell
incub
nm
three
compound
fig
f
supplementari
fig
wherea
addit
show
signific
effect
viru
product
nm
fig
supplementari
fig
maximum
effect
observ
nm
reduc
infect
viru
product
nearli
compound
nm
determin
whether
compound
effect
entri
step
chikv
infect
incub
cell
highest
concentr
compound
nm
increasingli
shorter
time
ad
infect
analyz
cell
supernat
hr
previou
experi
found
sulfonyl
amidin
effect
number
infect
cell
amount
viru
product
cell
compound
fig
saw
effect
ad
two
compound
fig
supplement
fig
show
effect
short
minut
wherea
sulfonyl
amidin
show
effect
number
cell
infect
hr
show
largest
effect
greatest
rang
time
point
effect
even
incub
hr
signific
effect
number
cell
infect
amount
viru
produc
may
mean
continu
inhibit
viru
entri
complet
prevent
wash
step
suggest
may
remain
associ
phb
longer
time
either
sulfonyl
amidin
howev
addit
hr
show
signific
effect
result
time
cours
experi
consist
action
compound
occur
attachmententri
step
chikv
infect
verifi
undertook
experi
short
minut
puls
wash
compound
infect
cell
treatment
short
period
possibl
could
use
higher
concentr
compound
verifi
treat
cell
minut
differ
concentr
compound
nm
wash
cell
twice
dmem
incub
standard
condit
hr
assess
cell
viabil
undertaken
previous
found
evid
loss
cell
viabil
even
highest
concentr
use
nm
supplementari
fig
therefor
repeat
experi
infect
cell
wash
chikv
assay
degre
infect
viru
product
hr
found
signific
reduct
infect
viru
product
condit
test
fig
supplementari
fig
viru
output
sulfonyl
amidin
reduc
nearli
puls
treatment
nm
compar
untreat
cell
final
confirm
compound
act
interf
receptor
bind
repeat
initi
coloc
experi
phb
chikv
time
presenc
absenc
compound
found
mark
reduct
coloc
chikv
phb
incub
viru
cell
presenc
compound
nm
compar
incub
compound
fig
high
degre
coloc
chikv
phb
pearson
correl
coeffici
ci
reduc
statist
significantli
degre
presenc
pearson
correl
coeffici
ci
p
pearson
correl
coeffici
ci
p
reduc
although
significantli
presenc
sulfonyl
amidin
pearson
correl
coeffici
ci
result
confirm
ligand
interfer
receptor
bind
chikv
prohibitin
locat
number
cell
compart
primarili
mitochondria
cell
surfac
express
also
demonstr
number
studi
phb
shown
interact
number
differ
pathogen
pathogen
protein
includ
chikv
dengu
sever
acut
respiratori
syndrom
coronaviru
hiv
diseas
viru
prohibitin
shown
specif
target
flavaglin
flavaglin
famili
natur
product
found
plant
genu
aglaia
famili
meliacea
mahogani
first
identifi
molecul
rocaglamid
rocaglamid
first
identifi
base
potent
activ
sinc
natur
synthet
flavaglin
shown
potent
properti
often
low
nanomolar
rang
recent
studi
suggest
flavaglin
includ
rocaglamid
silvestrol
promis
candid
treatment
leukemia
studi
shown
action
flavaglin
deriv
least
part
specif
interact
phb
flavaglin
studi
undertaken
determin
whether
interact
flavaglin
phb
suffici
disrupt
interact
phb
chikv
result
consist
compound
act
entri
stage
possibl
physic
interf
bind
chikv
phb
receptor
maximum
inhibit
observ
approxim
viral
entri
seen
puls
treatment
cell
degre
inhibit
consist
seen
previou
antibodi
inhibit
experi
compound
test
show
littl
effect
ad
may
suggest
flavaglin
limit
potenti
util
prophylact
agent
natur
infect
synchron
administr
cours
diseas
could
therapeut
effect
prevent
new
cell
becom
infect
fact
antibodi
inhibit
experi
compound
test
show
maximum
effect
entri
may
indic
chikv
use
multipl
receptor
protein
enter
suscept
cell
compound
test
show
signific
cytotox
cell
condit
continu
cultur
consist
compound
known
activ
howev
cytotox
observ
exposur
dramat
higher
dose
compound
administ
short
minut
puls
importantli
compound
show
toxic
normal
cell
display
evid
toxic
vivo
suggest
compound
inde
ligand
phb
could
form
basi
prophylact
therapeut
regim
chikv
outbreak
